Patents Assigned to CEPA SCHWARZ PHARMA, S.L.
  • ARYLPIPERAZINE DERIVATIVE AND USE THEREOF AS 5-HT1A RECEPTOR LIGANDS
    Publication number: 20090036455
    Abstract: Novel substituted arylpiperazine derivatives with activity as 5-hydroxytryptamine 1A (5-HT1A) receptor subtype ligands, to their stereochemical isomers, methods of their preparation, and to their use and to pharmaceutical compositions containing them for the treatment of Parkinson disease, cerebral damage by thromboembolic ictus, craneoencephalic traumatisms, depression, migraine, pain, psychosis, anxiety disorders, aggressive disorders or urinary tract disorders.
    Type: Application
    Filed: December 27, 2005
    Publication date: February 5, 2009
    Applicant: CEPA SCHWARZ PHARMA, S.L.
    Inventors: Maria Luz Lopez-Rodriguez, Bellinda Benhamu Salama